CytomX Therapeutics, Inc. CTMX
1.98 USD 0.00 (+0.00%)
At closeNov 11, 2026, 7:59 AM EST
2.03 +0.05 +2.53%
Pre-market · Nov 11, 7:59 AM ET
1.90 Day range 2.02
1.90 52-week range 8.21
- YTD
- -53.52%
- 1 year
- -52.74%
News
seekingalpha.com CytomX Therapeutics, Inc. (CTMX) Q3 2026 Earnings Call Transcript CytomX Therapeutics, Inc. ( CTMX ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Chris Ogden - SVP, CFO & Secretary Sean McCarthy - Chairman & CEO Conference Call…
benzinga.com Wedbush Maintains Outperform on CytomX Therapeutics, Raises Price Target to $12 Wedbush analyst Robert Driscoll maintains CytomX Therapeutics (NASDAQ:CTMX) with a Outperform and raises the price target from $11 to $12.
marketbeat.com CytomX Therapeutics Q3 Earnings Call Highlights CytomX Therapeutics NASDAQ: CTMX plans to provide a January update on its lead cancer drug candidate, Varseta-M, as it prepares for a potential registrational study in metastatic colorectal cancer in…
zacks.com CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.09 per share a year ago.
benzinga.com CytomX Therapeutics Q3 2026 Earnings Call Transcript CytomX Therapeutics (NASDAQ:CTMX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
globenewswire.com CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update - Varsetatug masetecan (Varseta-M) granted FDA Fast Track designation for relapsed/refractory metastatic colorectal cancer - - Phase 1 monotherapy data update in metastatic colorectal cancer (mCRC)…
benzinga.com CytomX Therapeutics Q3 EPS $(0.09) Beats $(0.10) Estimate, Sales $1.688M Miss $4.925M Estimate CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 0 percent. This is unchanged from the same period last year.…
seekingalpha.com CytomX Therapeutics: Trading Near Cash Value While Varseta-M Heads Toward Pivotal Trials CytomX Therapeutics is rated Buy, driven by positive clinical data for Varseta-M and a robust $367M cash runway after significant dilution. Varseta-M, targeting late-line colorectal cancer, achieved…
benzinga.com JP Morgan Maintains Overweight on CytomX Therapeutics, Lowers Price Target to $11 JP Morgan analyst Anupam Rama maintains CytomX Therapeutics (NASDAQ:CTMX) with a Overweight and lowers the price target from $12 to $11.- benzinga.com Guggenheim Maintains Buy on CytomX Therapeutics, Lowers Price Target to $14 Guggenheim analyst Michael Schmidt maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $15 to $14.
benzinga.com CytomX Therapeutics Q2 EPS $(0.09) Beats $(0.11) Estimate, Sales $1.418M Miss $12.308M Estimate CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. The company reported quarterly sales of $1.418…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Crude Oil Down 4%; Dollar Tree Earnings Top Views 
benzinga.com Nebius Group, CytomX Therapeutics, National Storage Affiliates Trust And Other Big Stocks Moving Higher On Monday Dow Jones index up 500 points; Nebius Group NV shares rise 12.7% on AI agreement with Meta Platforms; several other stocks record gains.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session - benzinga.com Market-Moving News for March 16th NBIS: 17% | Nebius Announced 5-Year $12B AI Infrastructure Agreement With Meta To Provide Dedicated Capacity Across Multiple Locations Using NVIDIA Vera Rubin Platform Starting Early 2027 CTMX: 70%
benzinga.com Earnings Scheduled For March 16, 2026 
benzinga.com Birkenstock, Insmed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session 
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million.
benzinga.com Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday 
benzinga.com This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday 
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Earnings Scheduled For May 12, 2025 - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For March 6, 2025
- benzinga.com Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.- benzinga.com Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis
- benzinga.com Earnings Scheduled For March 11, 2024 Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For August 8, 2023 Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
- benzinga.com Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top…
- benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
- benzinga.com Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers
- benzinga.com Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.
benzinga.com Earnings Scheduled For March 27, 2023 Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for…- benzinga.com Dow Jumps 700 Points; S&P 500 Rises Over 2% U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.
- benzinga.com Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 283 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
- benzinga.com Earnings Scheduled For August 4, 2022 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 49 companies set new 52-week lows.